
Novo Falls by Record After Wegovy Maker Slashes Forecast, Names New CEO
Bloomberg Intelligence
00:00
Challenges and Changes at Novo Nordisk
This chapter examines the latest challenges facing Novo Nordisk, including a significant reduction in sales and profit guidance due to market headwinds and competition. It discusses the appointment of a new CEO and the expectations for innovative leadership amid uncertainties in the obesity and diabetes markets. The chapter highlights the strategic direction the company may take as it navigates these competitive pressures and operational challenges.
Transcript
Play full episode